Hutch News

Hutch News

Stories tagged 'Computational Biology'

Good News at Fred Hutch

Celebrating faculty and staff achievements

March 10, 2016

Drs. Michael Emerman and Nina Salama elected to Fellowship in the American Academy of Microbiology; Dr. William Grady receives grant for esophageal cancer screening study; Dr. Andrew Hsieh earns 2016 ASCI Young Physician-Scientist Award; New interactive map is hub for global breast cancer data

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

March 3, 2016

Drs. Colleen Delaney, Harlan Robins named 2016 Leaders in Health Care; Hutch study finds CMV viral load can act as surrogate endpoint for clinical trials; A new target for Tumor Paint: BLZ-100 lights up head and neck cancers; Dr. Stephen Tapscott appointed to NIAMS advisory council

View story >


Reaching for answers

Researchers’ friends and family see scientists as conduits for hope

March 1, 2016 | By Bill Briggs / Fred Hutch News Service

Researchers often consider themselves conduits of science – and their conversations with the public are an accepted occupational responsibility for anyone donning a lab coat.

View story >


Building a better protein in the hope of better therapies

Researchers design and create donut-shaped proteins from scratch

Dec. 16, 2015 | By Dr. Rachel Tompa / Fred Hutch News Service

Researchers design and create donut-shaped proteins from scratch that could one day help yield more potent vaccines, more powerful growth factors to stimulate the growth of cancer-fighting immune cells in stem cell or cord blood transplants, or even a molecular sponge to soak up toxins in the body after poisoning.

View story >


Study sheds new light on molecular pathways behind marrow disorders

How a single alteration in fundamental cellular machinery drives blood diseases and cancers

May 11, 2015 | By Rachel Tompa / Fred Hutch News Service

Researchers have now uncovered how a single mutation can trigger myelodysplastic syndrome, or MDS, a disorder akin to leukemia in which the bone marrow overproduces some blood cell precursors but can’t convert them to healthy blood cells.

View story >


High-throughput sequencing outpaces flow cytometry for earliest detection of cancer relapse

Next-generation, high-speed DNA-decoding technology detects minimal residual disease in nearly double the number of leukemia patients than current gold standard method

May 21, 2012 | By Kristen Woodward

A study led by Fred Hutchinson Cancer Research Center Public Health Sciences Division computational biologist Dr. Harlan Robins has found that a next-generation, high-speed DNA-decoding technology called high-throughput sequencing can detect the earliest signs of potential relapse in nearly twice the number of leukemia patients as compared to flow cytometry, the current gold standard for detecting minimal residual disease.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.